Palo Alto Investors LP Long-Term Concentrated

Location: Palo Alto, CA

CIK: 0001306923 · Show all filings

Period: Q4 2019 (← Previous) (Next →)

Filing Date: Apr 8, 2020

Total Value: $1.816B (100.0% shares, 0.0% debt)

Holdings (37)

BMRN BIOMARIN PHARMACEUTICAL INC 9.4%
Value $171M Shares 2,021,136 Est. Cost $80.19 Unrealized -5.8%
INSM INSMED INC 9.0%
Value $164M Shares 6,848,760 Est. Cost $17.16 Unrealized +18.5%
EPIZYME INC 8.3%
Value $151M Shares 6,145,945 Est. Cost $15.12 Unrealized
STAA STAAR SURGICAL CO 7.3%
Value $133M Shares 3,778,938 Est. Cost $13.06 Unrealized +152.6%
IMMUNOMEDICS INC 6.9%
Value $125M Shares 5,923,195 Est. Cost $13.38 Unrealized
UTHR UNITED THERAPEUTICS CORP 6.3%
Value $114M Shares 1,288,902 Est. Cost $88.73 Unrealized -0.8%
AIMMUNE THERAPEUTICS INC 6.2%
Value $113M Shares 3,380,441 Est. Cost $22.84 Unrealized
ABIOMED INC 5.3%
Value $96.24M Shares 564,168 Est. Cost $37.80 Unrealized
ALEXION PHARMACEUTICALS INC 5.2%
Value $94.97M Shares 878,100 Est. Cost $121.54 Unrealized
KARYOPHARM THERAPEUTICS INC 4.8%
Value $88.09M Shares 4,595,001 Est. Cost $17.42 Unrealized
ACAD ACADIA PHARMACEUTICALS INC 4.5%
Value $81.51M Shares 1,905,374 Est. Cost $27.34 Unrealized +59.1%
WRIGHT MEDICAL GROUP NV 4.1%
Value $75.07M Shares 2,463,055 Est. Cost $23.42 Unrealized
VNDA VANDA PHARMACEUTICALS INC 4.1%
Value $74.26M Shares 4,525,476 Est. Cost $11.21 Unrealized +34.9%
FOLD AMICUS THERAPEUTICS INC 4.0%
Value $72.21M Shares 7,413,920 Est. Cost $7.59 Unrealized +20.5%
CLOVIS ONCOLOGY INC 2.9%
Value $52.71M Shares 5,056,286 Est. Cost $48.59 Unrealized
SAGE THERAPEUTICS INC 2.6%
Value $47.18M Shares 653,594 Est. Cost $48.62 Unrealized
AMAG PHARMACEUTICALS INC 2.0%
Value $37.05M Shares 3,044,374 Est. Cost $29.07 Unrealized
ALGN ALIGN TECHNOLOGY INC 2.0%
Value $35.58M Shares 127,505 Est. Cost $114.31 Unrealized +118.1%
MOMENTA PHARMACEUTICALS INC 1.8%
Value $33.25M Shares 1,685,372 Est. Cost $14.06 Unrealized
PRTA PROTHENA CORP PLC 0.9%
Value $15.71M Shares 992,749 Est. Cost $32.98 Unrealized -67.5%
PBYI PUMA BIOTECHNOLOGY INC 0.6%
Value $11.8M Shares 1,349,180 Est. Cost $28.90 Unrealized -71.4%
RIGEL PHARMACEUTICALS INC 0.4%
Value $7.581M Shares 3,542,551 Est. Cost $3.40 Unrealized
DICERNA PHARMACEUTICALS INC 0.4%
Value $7.31M Shares 331,813 Est. Cost $5.39 Unrealized
KLDO KALEIDO BIOSCIENCES INC 0.2%
Value $3.956M Shares 787,999 Est. Cost $13.76 Unrealized -53.8%
GILD GILEAD SCIENCES INC 0.1%
Value $2.554M Shares 39,300 Est. Cost $62.02 Unrealized -17.3%
ZOGENIX INC 0.1%
Value $1.538M Shares 29,500 Est. Cost $13.36 Unrealized
ALIMERA SCIENCES INC 0.1%
Value $1.523M Shares 200,919 Est. Cost $4.88 Unrealized
REVANCE THERAPEUTICS INC 0.1%
Value $1.438M Shares 88,590 Est. Cost $16.23 Unrealized
CYTK CYTOKINETICS INC 0.1%
Value $1.312M Shares 123,686 Est. Cost $6.71 Unrealized +53.0%
INTRA-CELLULAR THERAPIES INC 0.1%
Value $1.283M Shares 37,400 Est. Cost $34.30 Unrealized
ALDX ALDEYRA THERAPEUTICS INC 0.0%
Value $427K Shares 73,500 Est. Cost $7.53 Unrealized -23.3%
SUNESIS PHARMACEUTICALS INC 0.0%
Value $393K Shares 1,162,473 Est. Cost $4.37 Unrealized
MARINUS PHARMACEUTICALS INC 0.0%
Value $271K Shares 125,321 Est. Cost $4.17 Unrealized
MINERVA NEUROSCIENCES INC 0.0%
Value $258K Shares 36,319 Est. Cost $5.62 Unrealized
IDERA PHARMACEUTICALS INC 0.0%
Value $140K Shares 77,044 Est. Cost $8.90 Unrealized
SOPHIRIS BIO INC 0.0%
Value $91,000 Shares 247,000 Est. Cost $2.60 Unrealized
MELINTA THERAPEUTICS INC 0.0%
Value $5,000 Shares 10,137 Est. Cost $3.55 Unrealized